St
Stada Arzneimittel
Bad Vilbel DEFounded 189513,000 employees
Private CappharmaPrivateOncology
Platform: Consumer Health
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| STA-2404 | STA-2404 | NDA/BLA | 2 | CDK2 | Huntington's | ||
| STA-6220 | STA-6220 | Phase 1 | 1 | KRASG12C | RSVMS | ||
| Sovavorutinib | STA-3065 | Phase 2 | 2 | GIP-R | DLBCL | ||
| Nirasacituzumab | STA-5994 | Phase 2/3 | 2 | FGFR | HSPBC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)